In2Bones Overview

  • Founded
  • 2011

  • Status
  • Private

  • Employees
  • 62

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $255M

  • Investors
  • 1

In2Bones General Information


Operator of an orthopedic company intended to produce implants and instrumentation for the upper and lower extremities. The company leverages patented technology to develop fully pre-sterilized devices, and single-use instrument sets, and also provides a variety of products, enabling surgeons to alleviate pain and restore motion for their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
  • 6000 Poplar Avenue
  • Suite 115
  • Memphis, TN 38119
  • United States
+1 (844) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

In2Bones Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 04-May-2022 $255M 000.00 00000 Completed Generating Revenue
5. Later Stage VC 03-May-2019 00.00 000.00 Completed Generating Revenue
4. Later Stage VC 23-Oct-2017 00.000 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 20-Oct-2015 00.000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 28-Feb-2014 $4.09M $5.47M 0000 Completed Generating Revenue
1. Angel (individual) 22-Nov-2011 $1.37M $1.37M Completed Startup
To view In2Bones’s complete valuation and funding history, request access »

In2Bones Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
To view In2Bones’s complete cap table history, request access »

In2Bones Patents

In2Bones Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021357699-A1 Osteochondral/subchondral treatment system Pending 05-Oct-2021
CA-3194985-A1 Osteochondral/subchondral treatment system Pending 06-Oct-2020 00000000000
US-20220039810-A1 Metatarsal alignment apparatus Pending 10-Aug-2020 000000000
US-20220175436-A1 Metatarsal alignment apparatus Pending 10-Aug-2020 000000000
US-20210378722-A1 Bowed plate for fixating osteotomies and joint arthrodeses Pending 08-Jun-2020 A61B17/846 0
To view In2Bones’s complete patent history, request access »

In2Bones Executive Team (6)

Name Title Board Seat Contact Info
Alan Taylor Chief Executive Officer & President
Bruce Lawrence Chief Strategy Officer & Executive Chairman
Sheryl Moroschak Controller
Jean-Christophe Giet Director General
Bertrand Gauneau Co-Founder & Directeur Technique
You’re viewing 5 of 6 executive team members. Get the full list »

In2Bones Board Members (5)

Name Representing Role Since
Bruce Lawrence In2Bones Chief Strategy Officer & Executive Chairman 000 0000
Dennis Long Self Board Member 000 0000
You’re viewing 2 of 5 board members. Get the full list »

In2Bones Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

In2Bones Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Edmond de Rothschild Corporate Finance Investment Bank Minority 000 0000 000000 0
To view In2Bones’s complete investors history, request access »